Fisher opens custom synthesis unit in UK

Related tags Chemistry

Fisher Scientific has opened a new small scale chemical
manufacturing facility in Loughborough, UK, to add new custom
synthesis services for the pharmaceutical and other industries.

The unit has already started production of a number of commercially available and novel organic intermediates. It is designed to manufacture chemicals up to the 20 litre scale and is capable of performing all laboratory-based organic chemistry processes, according to the firm.

The laboratories contain 20 walk-in fume hoods and portable bench surfaces can be added. Analytical capabilities include high performance liquid chromatography (HPLC) and gas chromatography, as well as more routine testing.

Fisher​, perhaps better known as a supplier of laboratory equipment, instrumentation and reagents than for its custom synthesis activities, has been undergoing a phenomenal expansion over the last couple of years with the acquisition of the likes of Perbio Sciences, Oxoid and Dharmacon. And later this year it will add Apogent to its portfolio in a transaction scheduled to complete in the third quarter of this year.

Related news

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences | 28-Sep-2023 | White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs),...

Follow us

Products

View more

Webinars